Differential Regulation of Gene Expression by Protein Kinase C Isozymes as Determined by Genome-wide Expression Analysis*

Protein kinase C (PKC) isozymes are key signal transducers involved in normal physiology and disease and have been widely implicated in cancer progression. Despite our extensive knowledge of the signaling pathways regulated by PKC isozymes and their effectors, there is essentially no information on how individual members of the PKC family regulate gene transcription. Here, we report the first PKC isozyme-specific analysis of global gene expression by microarray using RNAi depletion of diacylglycerol/phorbol ester-regulated PKCs. A thorough analysis of this microarray data revealed unique patterns of gene expression controlled by PKCα, PKCδ, and PKCϵ, which are remarkably different in cells growing in serum or in response to phorbol ester stimulation. PKCδ is the most relevant isoform in controlling the induction of genes by phorbol ester stimulation, whereas PKCϵ predominantly regulates gene expression in serum. We also established that two PKCδ-regulated genes, FOSL1 and BCL2A1, mediate the apoptotic effect of phorbol esters or the chemotherapeutic agent etoposide in prostate cancer cells. Our studies offer a unique opportunity for establishing novel transcriptional effectors for PKC isozymes and may have significant functional and therapeutic implications.

[1]  C. Hauser,et al.  Ets2 and protein kinase C epsilon are important regulators of parathyroid hormone-related protein expression in MCF-7 breast cancer cells. , 2003, The Biochemical journal.

[2]  M. Ueffing,et al.  Two Closely Related Isoforms of Protein Kinase C Produce Reciprocal Effects on the Growth of Rat Fibroblasts , 1995, The Journal of Biological Chemistry.

[3]  A. Basu,et al.  Protein kinase Cε makes the life and death decision , 2007 .

[4]  F. Civoli,et al.  ET-18-OCH3 Inhibits Nuclear Factor-κB Activation by 12-O-Tetradecanoylphorbol-13-acetate but not by Tumor Necrosis Factor-α or Interleukin 1α , 1995 .

[5]  M. Kazanietz,et al.  Bryostatin 1 Inhibits Phorbol Ester-Induced Apoptosis in Prostate Cancer Cells by Differentially Modulating Protein Kinase C (PKC) δ Translocation and Preventing PKCδ-Mediated Release of Tumor Necrosis Factor-α , 2010, Molecular Pharmacology.

[6]  T. Kuroki,et al.  Protein kinase Cδ amplifies ceramide formation via mitochondrial signaling in prostate cancer cells , 2002 .

[7]  M. Kazanietz,et al.  Phorbol Ester-induced Apoptosis in Prostate Cancer Cells via Autocrine Activation of the Extrinsic Apoptotic Cascade , 2005, Journal of Biological Chemistry.

[8]  D. Terrian,et al.  Protein kinase Cɛ interacts with Bax and promotes survival of human prostate cancer cells , 2003, Oncogene.

[9]  M. Kazanietz,et al.  Protein kinase C isozymes, novel phorbol ester receptors and cancer chemotherapy. , 2001, Current pharmaceutical design.

[10]  M. Kazanietz,et al.  Regulation of Prostate Cancer Cell Survival by Protein Kinase Cϵ Involves Bad Phosphorylation and Modulation of the TNFα/JNK Pathway* , 2010, The Journal of Biological Chemistry.

[11]  D. Terrian,et al.  Protein Kinase Cε Has the Potential to Advance the Recurrence of Human Prostate Cancer , 2002 .

[12]  J. Falkenburg,et al.  Up-regulated expression in nonhematopoietic tissues of the BCL2A1-derived minor histocompatibility antigens in response to inflammatory cytokines: relevance for allogeneic immunotherapy of leukemia. , 2005, Blood.

[13]  S. Gringhuis,et al.  Convergent Actions of IκB Kinase β and Protein Kinase Cδ Modulate mRNA Stability through Phosphorylation of 14-3-3β Complexed with Tristetraprolin , 2005, Molecular and Cellular Biology.

[14]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[15]  N. Suttorp,et al.  PKCα and PKCϵ differentially regulate Legionella pneumophila-induced GM-CSF , 2009, European Respiratory Journal.

[16]  Yoav Benjamini,et al.  Identifying differentially expressed genes using false discovery rate controlling procedures , 2003, Bioinform..

[17]  P. Verde,et al.  Fra‐1 promotes growth and survival in RAS‐transformed thyroid cells by controlling cyclin A transcription , 2007, The EMBO journal.

[18]  S. Salzberg,et al.  JAK-STAT signaling involved in phorbol 12-myristate 13-acetate- and dimethyl sulfoxide-induced 2'-5' oligoadenylate synthetase expression in human HL-60 leukemia cells. , 2005, Leukemia research.

[19]  C. Gélinas,et al.  Constitutive proteasome-mediated turnover of Bfl-1/A1 and its processing in response to TNF receptor activation in FL5.12 pro-B cells convert it into a prodeath factor , 2005, Cell Death and Differentiation.

[20]  U. Förstermann,et al.  Differential roles of PKCalpha and PKCepsilon in controlling the gene expression of Nox4 in human endothelial cells. , 2008, Free radical biology & medicine.

[21]  A. Basu,et al.  Differential regulation of extrinsic and intrinsic cell death pathways by protein kinase C. , 2002, International journal of molecular medicine.

[22]  C. Crosio,et al.  Bcl2a1 serves as a switch in death of motor neurons in amyotrophic lateral sclerosis , 2006, Cell Death and Differentiation.

[23]  I. Verma,et al.  Cross-talk in signal transduction: TPA-inducible factor jun/AP-1 activates cAMP-responsive enhancer elements. , 1990, Oncogene.

[24]  A. Gutierrez-Hartmann,et al.  Role of specific protein kinase C isozymes in mediating epidermal growth factor, thyrotropin-releasing hormone, and phorbol ester regulation of the rat prolactin promoter in GH4/GH4C1 pituitary cells. , 2002, Molecular endocrinology.

[25]  C. Marshall,et al.  Activation of the Mitogen-Activated Protein Kinase/Extracellular Signal-Regulated Kinase Pathway by Conventional, Novel, and Atypical Protein Kinase C Isotypes , 1998, Molecular and Cellular Biology.

[26]  R. Tjian,et al.  Purified transcription factor AP-1 interacts with TPA-inducible enhancer elements , 1987, Cell.

[27]  A. Sytkowski,et al.  Protein kinase C-epsilon is necessary for erythropoietin's up-regulation of c-myc and for factor-dependent DNA synthesis. Evidence for discrete signals for growth and differentiation. , 1996, The Journal of biological chemistry.

[28]  M. O’Reilly,et al.  Tumor Necrosis Factor- α –Induced Lung Cell Expression of Antiapoptotic Genes TRAF1 and cIAP2 , 2000 .

[29]  N. Suttorp,et al.  Differential regulation of Moraxella catarrhalis-induced interleukin-8 response by protein kinase C isoforms , 2008, European Respiratory Journal.

[30]  P. Majumder,et al.  Protein kinase C delta inhibits Caco-2 cell proliferation by selective changes in cell cycle and cell death regulators , 2006, Oncogene.

[31]  W. Kolch,et al.  Overexpression of protein kinase C-delta and -epsilon in NIH 3T3 cells induces opposite effects on growth, morphology, anchorage dependence, and tumorigenicity. , 1993, The Journal of biological chemistry.

[32]  A. Suhrbier,et al.  SerpinB2 protection of retinoblastoma protein from calpain enhances tumor cell survival. , 2008, Cancer research.

[33]  S. Reddy,et al.  FRA-1 proto-oncogene induces lung epithelial cell invasion and anchorage-independent growth in vitro, but is insufficient to promote tumor growth in vivo. , 2007, Cancer research.

[34]  K. Belguise,et al.  FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells , 2005, Oncogene.

[35]  M. Kazanietz,et al.  Protein kinase C and other diacylglycerol effectors in cancer , 2007, Nature Reviews Cancer.

[36]  F. Feuerhake,et al.  Candidate genes for sensitivity and resistance of human glioblastoma multiforme cell lines to erlotinib. Laboratory investigation. , 2009, Journal of neurosurgery.

[37]  Peter J Parker,et al.  PKC at a glance , 2004, Journal of Cell Science.

[38]  John Calvin Reed,et al.  TRAF1 Is a Substrate of Caspases Activated during Tumor Necrosis Factor Receptor-α-induced Apoptosis* , 2001, The Journal of Biological Chemistry.

[39]  P A Insel,et al.  Protein kinase C isozymes and the regulation of diverse cell responses. , 2000, American journal of physiology. Lung cellular and molecular physiology.

[40]  P. Blumberg,et al.  Tyrosine Phosphorylation of Protein Kinase Cδ Is Essential for Its Apoptotic Effect in Response to Etoposide , 2002, Molecular and Cellular Biology.

[41]  K. Nakayama,et al.  Suppression of Apoptosis in the Protein Kinase Cδ Null Mouse in Vivo* , 2006, Journal of Biological Chemistry.

[42]  S. Anderson,et al.  Protein Kinase C δ Is Essential for Etoposide-induced Apoptosis in Salivary Gland Acinar Cells* , 1999, The Journal of Biological Chemistry.

[43]  M. Karin,et al.  Multiple cis- and trans-acting elements mediate the transcriptional response to phorbol esters , 1987, Nature.

[44]  R. Craig,et al.  Expression of the antiapoptotic MCL1 gene product is regulated by a mitogen activated protein kinase-mediated pathway triggered through microtubule disruption and protein kinase C , 1998, Oncogene.

[45]  S. Reddy,et al.  A JNK-Independent Signaling Pathway Regulates TNFα-Stimulated, c-Jun-Driven FRA-1 Protooncogene Transcription in Pulmonary Epithelial Cells1 , 2006, The Journal of Immunology.

[46]  T. Kuroki,et al.  Involvement of protein kinase C delta (PKCdelta) in phorbol ester-induced apoptosis in LNCaP prostate cancer cells. Lack of proteolytic cleavage of PKCdelta. , 2000, The Journal of biological chemistry.

[47]  R. Medcalf,et al.  Plasminogen Activator Inhibitor Type 2 Gene Induction by Tumor Necrosis Factor and Phorbol Ester Involves Transcriptional and Post-transcriptional Events , 1996, The Journal of Biological Chemistry.

[48]  L. Yin,et al.  Overexpression of PKCε sensitizes LNCaP human prostate cancer cells to induction of apoptosis by bryostatin 1 , 2006 .

[49]  J. Neoptolemos,et al.  Protein kinase C isoenzyme patterns characteristically modulated in early prostate cancer. , 1999, The American journal of pathology.